Search our Innovation Portfolio

HealthQuest has developed a web-based COPD self-management programme – myCOPD – that provides the necessary information, education, support and communications to give patients greater control over their disease, with consequent anticipated improvements in their clinical condition.

Glyconics has developed a device that uses Fourier-Transforming infrared spectroscopy (FTIR) for the analysis of sputum in patients with COPD, a condition for which accurate diagnosis is extremely difficult. The device can identify characteristic patterns of glycosylation in mucins in the sample, which allows a firm diagnosis of COPD to be made and to be differentiated from other forms of chronic lung disease. Furthermore, this pattern has been observed to change in the presence of an acute exacerbation, offering the opportunity to diagnose an incipient deterioration prior to it becoming clinically apparent.

Cambridge Respiratory Innovations’ overall aim is to develop an inexpensive COPD home health device specifically targeted at personal monitoring and treatment management. The device is simple to use and monitors normally exhaled carbon dioxide using III-V mid-infrared LEDs. The device helps COPD sufferers better manage their health and enables healthcare professionals to assess the effectiveness of treatment through periodic review of the data collected. It is hoped users will experience fewer uncontrolled exacerbations.